We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Can Intra-tumor Immunotherapy Reduce Side Effects?

News   Oct 24, 2018 | Original story from Houston Methodist

 
Implantable Drug-eluting Nanofluidic Device Delivers Immunotherapy

Smaller than a grain of rice, this tiny device, invented by a Houston Methodist nanoscientist, delivers immunotherapy straight into a tumor, eliminating both side effects and the need for multiple IV treatments. Credit: Houston Methodist

 
 
 

RELATED ARTICLES

Broccoli Compound Restores Potent Cancer Cell Suppressor Function

News

Researchers report that indole-3-carbinol (I3C) – a natural compound found in broccoli – can be used to therapeutically target a gene (WWP1) known to play a role in several human cancers.

READ MORE

Antiviral Immunity Differs in Stem Cells

News

A discovery of how stem cells are protected from viruses could inform the development of therapies for use in medicine.

READ MORE

Widely “Inconsistent” Use of Antibodies in Lab Experiments

News

Widespread inconsistencies have been affirmed in the use of a common laboratory procedure, immunohistochemical staining, throwing study results into doubt and shedding light on the “reproducibility crisis”.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE